Gentian Diagnostics ASA

DB:6FK Stock Report

Market Cap: €50.9m

Gentian Diagnostics Management

Management criteria checks 2/4

Gentian Diagnostics' CEO is Njaal Kind, appointed in Apr 2024, has a tenure of less than a year. total yearly compensation is NOK3.04M, comprised of 71.1% salary and 28.9% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth €86.20K. The average tenure of the management team and the board of directors is 1.9 years and 2.1 years respectively.

Key information

Njaal Kind

Chief executive officer

NOK 3.0m

Total compensation

CEO salary percentage71.1%
CEO tenureless than a year
CEO ownership0.2%
Management average tenure1.9yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Njaal Kind's remuneration changed compared to Gentian Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

NOK 2m

Jun 30 2024n/an/a

-NOK 2m

Mar 31 2024n/an/a

-NOK 6m

Dec 31 2023NOK 3mNOK 2m

-NOK 11m

Sep 30 2023n/an/a

-NOK 5m

Jun 30 2023n/an/a

-NOK 14m

Mar 31 2023n/an/a

-NOK 18m

Dec 31 2022NOK 3mNOK 2m

-NOK 24m

Sep 30 2022n/an/a

-NOK 29m

Jun 30 2022n/an/a

-NOK 26m

Mar 31 2022n/an/a

-NOK 26m

Dec 31 2021NOK 3mNOK 2m

-NOK 25m

Sep 30 2021n/an/a

-NOK 19m

Jun 30 2021n/an/a

-NOK 19m

Mar 31 2021n/an/a

-NOK 17m

Dec 31 2020NOK 2mNOK 2m

-NOK 17m

Sep 30 2020n/an/a

-NOK 21m

Jun 30 2020n/an/a

-NOK 19m

Mar 31 2020n/an/a

-NOK 38m

Dec 31 2019NOK 2mNOK 2m

-NOK 40m

Compensation vs Market: Njaal's total compensation ($USD268.43K) is below average for companies of similar size in the German market ($USD469.36K).

Compensation vs Earnings: Njaal's compensation has been consistent with company performance over the past year.

CEO

Njaal Kind

less than a year

Tenure

NOK 3,041,000

Compensation

Mr. Njaal Kind serves as Acting Chief Executive Officer since April 29, 2024 and Chief Financial Officer at Gentian Diagnostics AS and serves as its Chief Operating Officer. Mr. Kind has experience and ext...

Leadership Team

NamePositionTenureCompensationOwnership
Hilja Ibert
Executive Chairpersonless than a yearNOK 4.37m0.042%
€ 21.5k
Njaal Kind
Acting CEOless than a yearNOK 3.04m0.17%
€ 86.2k
Aleksandra Havelka
Chief Scientific Officer1.9yrsNOK 1.90m0.013%
€ 6.6k
Markus Jaquemar
Chief Commercial Officerno dataNOK 2.83mno data
Ingo Curdt
Head of Innovation & Research2.9yrsno datano data
Tom Nilsen
Head of Product Development2.9yrsno datano data

1.9yrs

Average Tenure

Experienced Management: 6FK's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Hilja Ibert
Executive Chairpersonless than a yearNOK 4.37m0.042%
€ 21.5k
Monika Neuman
Independent Director2.6yrsno datano data
Kari Krogstad
Independent Directorno datano data0.015%
€ 7.7k
Espen Jørgensen
Independent Directorno datano data0.11%
€ 56.1k
Kjersti Grimsrud
Non-Executive Independent Director1.6yrsno datano data
Fredrik Thoresen
Non-Executive Director2.6yrsno data0.18%
€ 92.9k

2.1yrs

Average Tenure

59yo

Average Age

Experienced Board: 6FK's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gentian Diagnostics ASA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinssonDNB Markets
Geir HolomDNB Markets